Schedule 13G ownership disclosure
Hancock Jaffe Laboratories, Inc.
Security class unavailable · CUSIP: 41015N106
Event date: 2020-07-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-019277
- Form type
- SC 13G
- Filer
- enVVeno Medical Corp
- CIK
- CIK 1661053
- Filed
- Jul 30, 2020
- Reporting period
- Jul 21, 2020
- Description
- Schedule 13G beneficial ownership